Fortis launches CATH LAB with 3D mapping Carto 7 machine
Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine
Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine
The cloud-based platform enables long-term brain monitoring towards personalized treatment
Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors
saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level
It is a recombinant nanoparticle protein-based vaccine
Subscribe To Our Newsletter & Stay Updated